325 related articles for article (PubMed ID: 28662159)
1. Pre-clinical carotid atherosclerosis and sCD163 among virally suppressed HIV patients in Botswana compared with uninfected controls.
Mosepele M; Hemphill LC; Moloi W; Moyo S; Nkele I; Makhema J; Bennett K; Triant VA; Lockman S
PLoS One; 2017; 12(6):e0179994. PubMed ID: 28662159
[TBL] [Abstract][Full Text] [Related]
2. HIV disease is associated with increased biomarkers of endothelial dysfunction despite viral suppression on long-term antiretroviral therapy in Botswana.
Mosepele M; Mohammed T; Mupfumi L; Moyo S; Bennett K; Lockman S; Hemphill LC; Triant VA
Cardiovasc J Afr; 2018 May/Jun 23; 29(3):155-161. PubMed ID: 29771268
[TBL] [Abstract][Full Text] [Related]
3. Soluble TWEAK may predict carotid atherosclerosis in treated HIV infection.
Dirajlal-Fargo S; Sattar A; Kulkarni M; Funderburg N; McComsey GA
HIV Clin Trials; 2017 Jul; 18(4):156-163. PubMed ID: 28828963
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms in the CD14 gene are associated with monocyte activation and carotid intima-media thickness in HIV-infected patients on antiretroviral therapy.
Yong YK; Shankar EM; Westhorpe CLV; Maisa A; Spelman T; Kamarulzaman A; Crowe SM; Lewin SR
Medicine (Baltimore); 2016 Aug; 95(31):e4477. PubMed ID: 27495090
[TBL] [Abstract][Full Text] [Related]
5. Subclinical cardiovascular disease in HIV controller and long-term nonprogressor populations.
Brusca RM; Hanna DB; Wada NI; Blankson JN; Witt MD; Jacobson LP; Kingsley L; Palella FJ; Budoff M; Brown TT; Anastos K; Lazar JM; Mack WJ; Bacchetti P; Tien PC; Golzar Y; Plankey M; Golub E; Kaplan RC; Post WS
HIV Med; 2020 Apr; 21(4):217-227. PubMed ID: 31729142
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular disease risk prediction by the American College of Cardiology (ACC)/American Heart Association (AHA) Atherosclerotic Cardiovascular Disease (ASCVD) risk score among HIV-infected patients in sub-Saharan Africa.
Mosepele M; Hemphill LC; Palai T; Nkele I; Bennett K; Lockman S; Triant VA
PLoS One; 2017; 12(2):e0172897. PubMed ID: 28235058
[TBL] [Abstract][Full Text] [Related]
7. Greater carotid intima media thickness at a younger age in HIV-infected patients compared with reference values for an uninfected cohort.
Krikke M; Arends JE; Van Lelyveld S; Hoepelman A; Visseren F
HIV Med; 2017 Apr; 18(4):275-283. PubMed ID: 27477496
[TBL] [Abstract][Full Text] [Related]
8. Elevated levels of monocyte activation markers are associated with subclinical atherosclerosis in men with and those without HIV infection.
McKibben RA; Margolick JB; Grinspoon S; Li X; Palella FJ; Kingsley LA; Witt MD; George RT; Jacobson LP; Budoff M; Tracy RP; Brown TT; Post WS
J Infect Dis; 2015 Apr; 211(8):1219-28. PubMed ID: 25362192
[TBL] [Abstract][Full Text] [Related]
9. Subclinical carotid atherosclerosis and cardiovascular risk factors in HIV-infected patients.
Kwiatkowska W; Knysz B; Drelichowska-Durawa J; Czarnecki M; Gąsiorowski J; Biłyk E; Karczewski M; Witkiewicz W
Postepy Hig Med Dosw (Online); 2011 Nov; 65():770-83. PubMed ID: 22173442
[TBL] [Abstract][Full Text] [Related]
10. Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients.
Burdo TH; Lo J; Abbara S; Wei J; DeLelys ME; Preffer F; Rosenberg ES; Williams KC; Grinspoon S
J Infect Dis; 2011 Oct; 204(8):1227-36. PubMed ID: 21917896
[TBL] [Abstract][Full Text] [Related]
11. Low CD4 Cell Counts Are Associated with Carotid Plaque and Intima-Media Thickness in Virologically Suppressed HIV-Infected Asians Older Than 50 Years.
Siwamogsatham S; Chutinet A; Vongsayan P; Samajarn J; Putcharoen O; Aponpong T; Hiransuthikul A; Gatechompol S; Han WM; Chattranukulchai P; Kerr SJ; Ruxrungtham K; Avihingsanon A;
AIDS Res Hum Retroviruses; 2019; 35(11-12):1160-1169. PubMed ID: 31530175
[TBL] [Abstract][Full Text] [Related]
12. Carotid Intima Media Thickness in Mainly Female HIV-Infected Subjects in Rural South Africa: Association With Cardiovascular but Not HIV-Related Factors.
Schoffelen AF; de Groot E; Tempelman HA; Visseren FL; Hoepelman AI; Barth RE
Clin Infect Dis; 2015 Nov; 61(10):1606-14. PubMed ID: 26215596
[TBL] [Abstract][Full Text] [Related]
13. Echolucency of the carotid artery intima-media complex and intima-media thickness have different cardiovascular risk factor relationships: the Women's Interagency HIV Study.
Jung M; Parrinello CM; Xue X; Mack WJ; Anastos K; Lazar JM; Selzer RH; Shircore AM; Plankey M; Tien P; Cohen M; Gange SJ; Hodis HN; Kaplan RC
J Am Heart Assoc; 2015 Feb; 4(2):. PubMed ID: 25699995
[TBL] [Abstract][Full Text] [Related]
14. The CD14 C-260T single nucleotide polymorphism (SNP) modulates monocyte/macrophage activation in treated HIV-infected individuals.
Rajasuriar R; Kong YY; Nadarajah R; Abdullah NK; Spelman T; Yuhana MY; Ponampalavanar S; Kamarulzaman A; Lewin SR
J Transl Med; 2015 Jan; 13():30. PubMed ID: 25622527
[TBL] [Abstract][Full Text] [Related]
15. Burden of subclinical carotid atherosclerosis and vascular risk factors among people living with HIV in Ghana.
Sarfo FS; Nichols M; Agyei B; Singh A; Ennin E; Nyantakyi AD; Asibey SO; Tagge R; Gebregziabher M; Jenkins C; Ovbiagele B
J Neurol Sci; 2019 Feb; 397():103-111. PubMed ID: 30599299
[TBL] [Abstract][Full Text] [Related]
16. Effects of aging and smoking on carotid intima-media thickness in HIV-infection.
Fitch KV; Looby SE; Rope A; Eneh P; Hemphill L; Lee H; Grinspoon SK
AIDS; 2013 Jan; 27(1):49-57. PubMed ID: 22874518
[TBL] [Abstract][Full Text] [Related]
17. Hypertensive Versus HIV-infected Patients: Who Has the Greatest Target Organ Damage? Comparison of Carotid Plaque Prevalence, Intima Media Thickness and Renal Resistive Index in the Two Groups of Patients.
Taramasso L; Mirabella M; Cappadona F; Bonino B; Riccardi N; Cenderello G; De Socio GV; Viscoli C; Viazzi F; Di Biagio A
Curr Hypertens Rev; 2018; 14(1):48-55. PubMed ID: 29521243
[TBL] [Abstract][Full Text] [Related]
18. Associations between surface markers on blood monocytes and carotid atherosclerosis in HIV-positive individuals.
Westhorpe CL; Maisa A; Spelman T; Hoy JF; Dewar EM; Karapanagiotidis S; Hearps AC; Cheng WJ; Trevillyan J; Lewin SR; Sviridov D; Elliott JH; Jaworowski A; Dart AM; Crowe SM
Immunol Cell Biol; 2014 Feb; 92(2):133-8. PubMed ID: 24296810
[TBL] [Abstract][Full Text] [Related]
19. During Hepatitis C Virus (HCV) Infection and HCV-HIV Coinfection, an Elevated Plasma Level of Autotaxin Is Associated With Lysophosphatidic Acid and Markers of Immune Activation That Normalize During Interferon-Free HCV Therapy.
Kostadinova L; Shive CL; Judge C; Zebrowski E; Compan A; Rife K; Hirsch A; Falck-Ytter Y; Schlatzer DM; Li X; Chance MR; Rodriguez B; Popkin DL; Anthony DD
J Infect Dis; 2016 Nov; 214(9):1438-1448. PubMed ID: 27540113
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory biomarkers and subclinical carotid atherosclerosis in HIV-infected and HIV-uninfected men in the Multicenter AIDS Cohort Study.
Subramanya V; McKay HS; Brusca RM; Palella FJ; Kingsley LA; Witt MD; Hodis HN; Tracy RP; Post WS; Haberlen SA
PLoS One; 2019; 14(4):e0214735. PubMed ID: 30946765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
